TY - JOUR
T1 - Show Me CKDintercept Initiative
T2 - A Collective Impact Approach to Improve Population Health in Missouri
AU - Laue, Katelyn
AU - Schultz, Megan
AU - Talbot-Montgomery, Elizabeth
AU - Garrick, Alexandra
AU - Java, Anuja
AU - Corbett, Christine
AU - Lammert, Dana M.
AU - Rogers, Jo Anna
AU - Davis, Kathleen
AU - Malhotra, Kunal
AU - Philipneri, Marie
AU - Kimbel, Mary Ann
AU - Mustafa, Reem A.
AU - Hardesty, Valerie
N1 - Publisher Copyright:
© 2023
PY - 2024/2
Y1 - 2024/2
N2 - Ninety percent of people with chronic kidney disease (CKD) remain undiagnosed, most people at risk do not receive guideline-concordant testing, and disparities of care and outcomes exist across all stages of the disease. To improve CKD diagnosis and management across primary care, the National Kidney Foundation launched a collective impact (CI) initiative known as Show Me CKDintercept. The initiative was implemented in Missouri, USA from January 2021 to June 2022, using a data strategy, stakeholder engagement and relationship mapping, learning in action working groups (LAWG), and a virtual leadership summit. The Reach, Effectiveness, Adoption, Implementation, and Maintenance framework was used to evaluate success. The initiative united 159 stakeholders from 81 organizations (Reach) to create an urgency for change and engage new CKD champions (Effectiveness). The adoption resulted in 53% of participants committed to advancing the roadmap (Adoption). Short-term results reported success in laying a foundation for CI across Missouri. The long-term success of the CI initiative in addressing the public health burden of kidney disease remains to be determined. The project reported the potential use of a CI initiative to build leadership consensus to drive measurable public health improvements nationwide.
AB - Ninety percent of people with chronic kidney disease (CKD) remain undiagnosed, most people at risk do not receive guideline-concordant testing, and disparities of care and outcomes exist across all stages of the disease. To improve CKD diagnosis and management across primary care, the National Kidney Foundation launched a collective impact (CI) initiative known as Show Me CKDintercept. The initiative was implemented in Missouri, USA from January 2021 to June 2022, using a data strategy, stakeholder engagement and relationship mapping, learning in action working groups (LAWG), and a virtual leadership summit. The Reach, Effectiveness, Adoption, Implementation, and Maintenance framework was used to evaluate success. The initiative united 159 stakeholders from 81 organizations (Reach) to create an urgency for change and engage new CKD champions (Effectiveness). The adoption resulted in 53% of participants committed to advancing the roadmap (Adoption). Short-term results reported success in laying a foundation for CI across Missouri. The long-term success of the CI initiative in addressing the public health burden of kidney disease remains to be determined. The project reported the potential use of a CI initiative to build leadership consensus to drive measurable public health improvements nationwide.
UR - http://www.scopus.com/inward/record.url?scp=85190268877&partnerID=8YFLogxK
U2 - 10.1016/j.mayocpiqo.2023.12.004
DO - 10.1016/j.mayocpiqo.2023.12.004
M3 - Article
C2 - 38283097
AN - SCOPUS:85190268877
SN - 2542-4548
VL - 8
SP - 82
EP - 96
JO - Mayo Clinic Proceedings: Innovations, Quality and Outcomes
JF - Mayo Clinic Proceedings: Innovations, Quality and Outcomes
IS - 1
ER -